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Purpose: The purpose of this study was to evaluate the annual changes in prostate varia-
bles and style of surgical treatment of patients with benign prostatic hyperplasia (BPH) 
over the past 12 years.
Materials and Methods: The subjects were 918 patients (January 1999-November 
2010) who were treated by either open prostatectomy or transurethral resection of pro-
state (TURP). Every year, the performance ratio between open prostatectomy and 
TURP was evaluated. Before surgery, total and transitional zone volumes of the pro-
state were measured by transrectal ultrasonography (TRUS). After surgery, resection 
weight and residual volume of the prostate were measured by TRUS.
Results: From 2001 through 2010, the performance ratio of TURP increased greatly 
from 89% to 97%. During 1999 to 2010, the total volume of the prostate increased from 
40.0 cc to 55.0 cc in the TURP group and from 74.1 cc to 116.7 cc in the open prostatectomy 
group. During 1999 to 2010, the mean resection volume of the TURP group increased 
from 2.3 cc to 20.1 cc. Also, the mean resection volume of the open prostatectomy group 
increased from 59.3 cc to 114.3 cc. During 1999 to 2003, the resection time of the TURP 
group decreased from 72.9 minutes to 43.2 minutes.
Conclusions: During 1999 through 2010, the performance ratio between open prosta-
tectomy vs TURP was high for TURP. The total volume and resection volume of the 
prostate increased annually, and the resection time decreased annually.
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Benign prostatic hyperplasia (BPH) is the main reason for 
lower urinary tract symptoms (LUTS) due to urethral 
blockade. There are two kinds of treatments for patients 
with BPH: medical and surgical treatment. Whereas medi-
cal treatment using alpha-blockers or 5-alpha reductase 
inhibitors is the first-line treatment of BPH, in some in-
effective cases, open prostatectomy or transurethral resec-
tion of prostate (TURP) has been mainly applied. Approxi-
mately 10% of patients with BPH require surgical treat-
ment [1]. In some cases, surgery could be the first choice 
for treatment rather than medical therapy. Approximate-
ly 8% of subjects receiving medical therapy require sub-
sequent surgical therapy [2]. Delay of surgical therapy due 
to medical therapy can cause progression of BPH and its 
symptoms.
　Recently, non-open surgery, or TURP, has been more 
popularly used because of the lower mortality and shorter 
hospital stay than with open surgery. Development of 
equipment such as high-quality resectoscopes and fiber-
optic and microlens systems and advances in the technol-
ogy of TURP also contribute to a higher rate of TURP than 
open surgery [3]. The purpose of this article was to evaluate 
the annual changes in prostate variables and style of surgi-
cal treatment in patients with BPH over the past 12 years.Korean J Urol 2011;52:189-193
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Age (yr)  67.9±7.2 72.1±6.3 0.543





22.2±14.0 57.1±25.9  0.024
Resection volume (cc) 18.7±16.2  81.3±36.7  ＜0.001
Preoperative IPSS 21.8±8.2 22.3±8.4 0.645
Postoperative IPSS 14.6±11.9 14.7±7.6 0.833
TURP: transurethral resection of the prostate, IPSS: Interna-
tional Prostate Symptom Score
TABLE 2. Comparisons between 1999 vs. 2010 in the TURP and 
open prostatectomy groups
1999 2010 p-value
Performance ratio of 
TURP (%)
64.0±5.6 97.5±6.2 0.026
Total prostate volume of 
TURP (cc)
46.2±4.3 55.2±3.4 0.031
Resection volume of 
TURP (cc)
2.5±1.2 20.1±12.6 ＜0.001
Performance ratio of open
prostatectomy (%)
42.9±5.6 2.5±1.3 ＜0.001
Total prostate volume of 
open prostatectomy (cc)
74.1±20.3 116.7±52.2 0.016
Resection volume of open
prostatectomy (cc)
59.3±1.2 82.9±32.6 0.025
TURP: transurethral resection of the prostate
MATERIALS AND METHODS
The subjects were 918 patients (January 1999-November 
2010) who were treated by either open prostatectomy or 
TURP. For the preoperative evaluation, chest x-ray, intra-
venous pyelography, electrocardiography (ECG), urine 
analysis, urine culture, blood tests, and biochemistry tests 
were done. In patients who were more than 60 years of age, 
arterial blood gas analysis (ABGA) was performed. Also, 
all patients underwent transrectal ultrasonography (TRUS, 
B&K Medical, Herlev, Denmark), digital rectum examina-
tion (DRE), and serum prostate-specific antigen (PSA) 
measurement. All patients were treated by the same sur-
geon in our hospital. A monopolar electric surgical unit and 
24 Fr resectoscope (Karl Storz
TM, Tuttlingen, Germany) 
and a continuous irrigation system were used until 2003, 
and a 22 Fr resectoscope (Karl Storz
TM, Tuttlingen, Ger-
many) since 2004. All patients underwent TURP with spi-
nal or general anesthesia.
　Every year, the performance ratio between open prosta-
tectomy and TURP was evaluated. Before surgery, the to-
tal volume of the prostate was measured by TRUS. All pa-
tients underwent TRUS by residents (2 second-year resi-
dents per year, 22 residents/12 years) in our urology de-
partment. In addition, before both TURP and open prosta-
tectomy, the peak flow rate (PFR; Qmax), residual volume, 
and International Prostate Symptom Score (IPSS) were 
evaluated, and just after removal of the Foley catheter in 
both surgeries, Qmax, residual volume, and IPSS were 
measured. Resection volume was measured as follows. 
After TURP, resected prostate tissue was obtained and 
measured by use of a weighing machine. Resection time 
was measured as the duration from start to end of cutting 
the prostate. Postoperative complications were compara-
tively analyzed. Since 2006, the residual volume and re-
section time were measured. Follow-up data of perform-
ance ratio, prostate volume, resection volume, resection 
time, IPSS, and complications were analyzed by using 
SPSS ver. 17.0 (SPSS Inc., Chicago, IL, USA). Comparisons 
of clinical characteristics and parameters were made by us-
ing the paired t-test and chi-square test. Values of p＜0.05 
were considered significant.
RESULTS
The mean age of the 843 patients who underwent TURP 
was 67.9±7.2 years (range, 46-88 years) and the mean age 
of the 75 patients who underwent open prostatectomy was 
72.1±6.3 years (range, 58-83 years). The mean total volume 
of TURP was 43.6±19.4 cc (range, 14-98 cc) and that for open 
prostatectomy was 102.1±31.3 cc (range, 52-213 cc). The 
mean weight of the resected volume was 18.7±16.2 cc 
(range, 2-54 cc) in the TURP group and 81.3±36.7 cc (range, 
21-140 cc) in the open prostatectomy group. In the TURP 
group, the mean preoperative IPSS score was 21.8±8.2 and 
the mean postoperative IPSS score was 14.6±11.9. In the 
open prostatectomy group, the mean preoperative IPSS 
score was 22.3±8.4 and the mean postoperative IPSS score 
was 14.7±7.6. Between the TURP and open prostatectomy 
groups, total prostate volume, transitional zone volume, 
and resection volume were significantly different (p＜ 
0.001, p=0.024, p＜0.001, respectively) (Table 1).
　The performance ratio between open prostatectomy and 
TURP treatment was 64% vs 36% in 1999 and 3% vs 97% 
in 2010. In 2001 the performance ratio of TURP started to 
increase over open prostatectomy as 94.5% vs 5.5%, and 
during 2001 through 2010, the performance ratio of TURP 
greatly increased (Table 2, Fig. 1). From 1999 to 2010, the 
total prostate volume of the TURP group increased from 
40.0 cc to 55.0 cc, which was a significant difference 
(p=0.031) (Table 2, Fig. 2). From 1999 to 2010, the total 
prostate volume also showed an increase from 74.1 cc to 
116.7 cc in the open prostatectomy group, which was a sig-
nificant difference (p=0.016) (Table 2, Fig. 2). From 1999 
to 2010, the mean resection volume of the TURP group in-
creased from 2.3 cc to 20.1 cc, which was a significant differ-
ence (p＜0.001) (Table 2, Fig. 2). Also, the mean resection 
volume of the open prostatectomy group increased from 
59.3 cc to 114.3 cc, which was a significant difference Korean J Urol 2011;52:189-193
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FIG. 1. The performance ratio of transurethral resection of the 
prostate and open prostatectomy. TURP: transurethral resection
of prostate.
FIG. 3. The resection volume per minute of TURP. TURP: tran-
surethral resection of prostate.
FIG. 4. Occurrence of urethral strictures after TURP. TURP: tran-
surethral resection of prostate.
FIG. 2. The total prostate volume and resection volume in the tran-
surethral resection of the prostate group and open prostatectomy 
group. TURP: transurethral resection of prostate.
(p=0.025) (Table 2, Fig. 2). In the beginning of TURP, the 
surgeon preferred to perform open prostatectomy rather 
than TURP, because the operator was not as experienced 
with TURP as with open prostatectomy.
　From 2006 to 2010, the residual volume of the prostate 
after TURP decreased from 29.3 cc to 24.7 cc. From 1999 
to 2010 the resection time of the TURP group decreased 
from 72.9 minutes to 43.2 minutes, which was significant 
difference (p=0.031) (Table 2). Also, the resection volume 
per minute of TURP increased from 0.03 cc to 0.46 cc (Fig. 
3). There was no significant difference between post-
operative Qmax and postoperative IPSS in 1999 to 2010. 
Urethral dilatation and internal urethrotomy to treat the 
urethral stricture gradually increased between 1999 and 
2005 such as from 4.0% to 49.1%. Between 2005 and 2010, 
urethral strictures decreased from 49.1% to 9.2% (Fig. 4). 
There was no significant difference between the frequency 
of cystocatheterization and reoperation due to postopera-
tive bleeding.
　Also, the performance ratio, total prostate volume, and 
resection volume were higher and resection time was lower 
in the TURP group who underwent the procedure with the 
22 Fr resectoscope from 2004 to 2010. Regardless of resecto-
scope size, the performance ratio, total prostate volume, 
and resection volume increased annually and resection 
time decreased annually. Also, the incidence of urethral 
stricture after TURP was not significantly different in ei-
ther group (p=0.131) (Table 3).
DISCUSSION
BPH, the most common benign neoplasm in men, is clin-
ically followed by LUTS. These variable symptoms range 
from incomplete emptying, nocturia, weak stream, to fre-
quency and can potentially advance to urge incontinence, Korean J Urol 2011;52:189-193
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TABLE 3. Comparison between 24 Fr resectoscope (1999-2003) vs
22 Fr resectoscope (2004-2010)
1999-2003 2004-2010 p-value
Performance ratio of 
TURP (%)
 75±4.8 93.2±8.2 0.015
Total prostate volume of 
TURP (cc)
43.6±5.3 52.3±3.6 0.041
Resection volume of 
TURP (cc)
10.2±2.3 18.3±11.2 0.023
Resection time of TURP 
(minute)
63.5±15.1 52.1±9.4 0.018
Incidence of urethral 
stricture (%)
20.5±3.2 22.4±4.1 0.131
TURP: transurethral resection of the prostate
urinary retention, urinary tract infection (UTI), bladder 
calculi, or renal failure. LUTS impede habitual activities 
and reduce quality of life [4,5].
　In order to relieve bladder outlet obstruction, the tran-
surethral operation was started by Pare in the 16th century 
[6]. In 1926, Stearns developed the tungsten loop, which 
could be used for the resection, and the transurethral re-
section procedure widely spread [7]. The indications for 
TUR are as follows: complete urinary obstruction with 
prostate blockade syndrome, urinary obstruction symp-
toms, recurrent bleeding, and recurrent UTI [8]. With the 
increase in the population of old aged persons and im-
proved medical service, the number of BPH patients has 
increased. Among them are patients in their 60s and 70s 
who need to be operated on because they have diseases such 
as lung disease, diabetes mellitus, and hypertension [9]. 
TUR can be conducted in persons who can live longer than 
6 months with other internal organ tumors. The selection 
of a treatment method can be accomplished by considering 
the patient's physical condition, accompanying diseases, 
the size and shape of the prostate, expected complications, 
and surgeon's technique.
　The treatment methods of BPH are classified as medical 
and surgical treatments. The surgical treatments can be 
classified as open prostatectomy and TURP treatment in 
general. TURP still represents the surgical treatment of 
choice for prostate glands up to 100 ml, whereas open pros-
tatectomy is indicated for prostate glands larger than 80 
to 100 ml [10,11]. Generally, in cases of much more than 
100 g of prostate volume, open prostatectomy will be recom-
mended [12]. However, Kwak et al reported on a compar-
ison between TURP and open prostatectomy for patients 
with large BPH, and there were no significant differences 
in effectiveness or safety for 5 years. Even for patients with 
BPH with a high volume, TURP is an effective operation 
that can replace open prostatectomy [13]. When selecting 
the proper treatment methods for BPH, not only the many 
factors already listed previously but also the anticipated 
complications must be seriously considered [12]. Usually, 
TURP is conducted more often than open prostatectomy be-
cause the former is not only less invasive but also is asso-
ciated with less morbidity. TURP is the gold standard for 
the surgical management of symptomatic BPH and has 
proven to be a highly efficient technique associated with a 
low mortality rate [14-16]. However, after TURP, several 
complications such as incontinence, stricture of the ure-
thra, and retrograde ejaculation may develop [7]. In our da-
ta, urethral dilatation and internal urethrotomy to treat 
the urethral stricture gradually increased between 1999 
and 2005 from 4.0% to 49.1%. Between 2005 and 2010, how-
ever, the rate of urethral strictures decreased from 49.1% 
to 9.2%. From 2006, we started to maintain the temper-
ature of the urethra with warm irrigation solution during 
transurethral resection of the prostate. This decreased the 
incidence of urethral stricture compared with the room- 
temperature irrigation solution group. We observed that 
a lower temperature might be another cause of urethral 
stricture after TURP. The mechanical damage in the ure-
thral mucosa leads to leakage of urine, resulting in in-
flammation and scar formation [17]. Resectoscope size, 
however, did not have a significant relationship with the 
incidence of urethral stricture.
　Developments in anesthesia, for example, the addition 
of opioids to local anesthetics, have reduced the side effects 
of spinal anesthesia in urologic surgery [18]. Owning to new 
techniques, the operation time has been reduced and com-
plications have declined. Because of the high quality of the 
resectoscope, and the fiberoptic and microlens systems, 
and strict adherence to the practice of performing TURP, 
the results of the present study also demonstrate that the 
safety of TURP is improved by decreasing intraoperative 
blood loss, which significantly decreases the need for blood 
transfusion [19]. For these reasons, TURP has been widely 
performed rather than open prostatectomy during the past 
12 years in urology. This is the trend in the treatment of 
patients with BPH.
　In general, surgeons start an operation with an easy 
case, which is followed by difficult ones. The learning curve 
migrates from small prostate cases to large prostate cases. 
In our data, prostate volume was larger during the latter 
period than in the early period because of improved techni-
ques of TURP. In addition, TURP efficiency increased in 
proportion to prostate weight, and this study showed a con-
tinuous increase in resection volume per minute of TURP.
　The introduction of medical therapy for symptomatic 
BPH resulted in a delay in the need for surgical inter-
vention, such that a man who eventually required TURP 
inevitably presents when older, with a worsening comorbid 
status, and more progressive disease, thus resulting in 
poorer outcomes and more frequent postoperative compli-
cations [20]. Also, delay in surgical therapy results in the 
progression of BPH. This can lead to more extensive and 
complicated resection. Patients treated by TURP show an 
increase in not only prostate volume but also resected pros-
tate volume, which may be because the surgery was de-
layed by treatment with alpha-1 blockers or 5-alpha reduc-
tase inhibitors. The volume of the prostate removed by open 
prostatectomy also increased, which may also have been Korean J Urol 2011;52:189-193
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caused by the delayed surgical effect by medication [20], al-
though that should be followed up for a longer time.
CONCLUSIONS
From 1999 through 2010, the performance ratio between 
open prostatectomy and TURP was higher for TURP. The 
total and resection volumes of the prostate increased 
annually. The increases in prostate volume and resected 
prostate volume may have occurred because the surgery 
was delayed by the improvement in symptoms by medi-
cations. Also, the resection time and postoperative compli-
cations decreased annually as the result of improvements 
in surgical techniques and instruments.
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